“Agriculture faces dual challenges: becoming more sustainable on a dwindling resource base while having to feed an increasing number of people,” Paul Polman, CEO of consumer goods company Unilever, and David Servitje, CEO of baking company Group Bimbo, who serve as co-chairs of the G20’s B-20 Food Security Task Force, write in a Washington Post opinion piece, adding, “To provide food and nutrition security in the coming decades will require a major and sustained effort by all stakeholders, including business.” They continue, “The good news is that food security is firmly on the political agenda of the Group of Eight, the Group of 20 and at this week’s U.N. Conference on Sustainable Development (Rio+20). And business has been invited to contribute.”
Private Sector Involvement
Discussing the meeting of G20 leaders taking place this week in Los Cabos, Mexico, the Financial Times states, “Food security, long only a concern for aid advocates and farming ministers, is now hotly debated among G20 leaders.” Though food prices have stabilized recently, they are much higher than in the past, causing widespread food insecurity and leading to about one billion chronically hungry people worldwide, the newspaper notes. The “initial reaction” of the G20, and the G8, was to supply emergency food aid, “[b]ut as the era of high food prices appears to be here to stay, the focus of the G20 is slowly shifting from fighting the emergency to addressing the long-term problem,” the Financial Times writes.
U.N. Food And Agriculture Agencies Urge G20 To Increase Efforts To Fight Hunger; G20 Launches AgResults Initiative
As G20 leaders wrapped up their meeting in Los Cabos, Mexico, on Tuesday, the U.N. food and agriculture agencies — the Food and Agriculture Organization (FAO), the International Fund for Agricultural Development (IFAD) and the World Food Programme (WFP) — issued a joint statement “call[ing] on them to redouble their efforts to fight hunger” and “welcom[ing] the priority given to food and nutrition security at the summit,” the U.N. News Centre reports. The agencies “noted that food security is closely linked to other issues on the agenda of G20 — such as infrastructure development and restoring growth in countries in crisis” — and emphasized the role of partnerships in improving food security, according to the news agency. The “agencies also welcomed the continuing recognition by the G20 of the pivotal role of smallholder agriculture to global food security and to boosting productivity in a sustainable manner,” the news agency writes (6/19).
In this post in PSI’s “Healthy Lives” blog, Deputy Editor Tom Murphy discusses the Saving Mothers, Giving Life initiative, which “support[s] the aggressive reduction of maternal mortality in countries with the highest mortality rates.” He notes that the “founding partners include the U.S. Global Health Initiative (GHI), Merck for Mothers, American College of Obstetricians and Gynecologists (The College), Every Mother Counts (EMC), and the Government of Norway,” and that they have pledged $200 million over five years. Murphy outlines the objectives of the initiative and highlights some of the comments made at its launch last week during the Child Survival Call to Action summit (6/19).
“Following the launch of the PLoS Medicine series on Big Food and the publication of the first three articles in the series last week,” Clare Weaver of the journal’s “Speaking of Medicine” blog interviews David Stuckler, a lecturer in sociology at the University of Cambridge and one of the guest editors of the series, about his research background and some of the issues related to the series. Some of the topics discussed include why it is “important that a major medical journal examine the food industry and its influence in global health,” why this is an international issue rather than one limited to developed countries, and what further research is needed in the area (6/25).
As the BRIC countries — Brazil, Russia, India, and China — invest more in innovations in health technologies and other areas, “many are looking to these countries to correct the global health research and development (R&D) imbalance that leaves the poor without needed products such as an improved tuberculosis (TB) vaccine or tests to help diagnose patients in remote rural settings,” David de Ferranti, president of Results for Development Institute (R4D), writes in the Huffington Post Blog. Writing that “India, which has already played such an important role in manufacturing affordable antiretroviral drugs, vaccines, and other essential health commodities for developing countries,” de Ferranti asks whether India “is … ready to play a leading role in health R&D?”
“British mobile phone group Vodafone and drug maker GlaxoSmithKline are joining forces on a novel project to increase childhood vaccination rates in Mozambique using text messaging,” Reuters reports. With the aim of increasing the proportion of children covered by vaccination by five to 10 percent, a one-year pilot project supported by Save the Children “will register mothers on a ministry of health database, alert them to the availability of vaccinations and allow them to schedule appointments by text,” the news agency notes. In addition, a three-year partnership between Vodafone and the GAVI Alliance, supported by the British government, will “study how health ministries across sub-Saharan Africa can use mobile technology to improve their immunization programs,” Reuters notes, adding, “Britain will match Vodafone’s contribution of technology and services with a $1.5 million cash contribution to GAVI” (12/10).
“In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday,” Xinhua/Global Times reports. “Rwanda and Uganda have been conducting HPV pilot projects through donations from vaccine manufacturers and are expected to roll out the vaccine nationwide with GAVI support in 2014,” the news service writes, adding, “By 2015, GAVI plans to immunize approximately one million girls with HPV vaccines and a large number of other countries are expected to run HPV pilot projects, and by 2020, more than 30 million girls will be immunized against HPV, [GAVI Alliance CEO Seth] Berkley said” (12/7).
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled “Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations.” The following is a list of those posts.
Nick Chapman, a policy analyst at Policy Cures, writes in a guest post on the Global Health Technologies Coalition’s “Breakthroughs” blog about “the results of the latest G-FINDER survey on global funding of [research and development (R&D)] for neglected diseases.” He discusses several findings and trends from the report, including the impact of the global financial recession on R&D funding; the relatively stable level of U.S. funding; the concentration of pharmaceutical company funding to “a limited number of diseases with some commercial overlap, such as dengue fever, bacterial pneumonia and meningitis, and tuberculosis (TB)”; the shift away from product development funding from public funders; and the effect of these trends on product development partnerships (PDPs) (Lufkin, 12/19).